Trump says experimental drugs may have saved him from virus

WASHINGTON (AP) — President Donald Trump said Friday he could have become very ill and might not have recovered from COVID-19 without experimental drugs, a far worse outlook than what his doctors were telling the American people.

“I was asking the doctors today … and I said, ‘How bad was I?’ They said: ‘You could have been very bad. You were going into a very bad phase,'” Trump told Rush Limbaugh during his radio show.

“It looked like it was going to be a big deal and you know what that means, right? That means bad because I’ve lost five people,” Trump added, referring to acquaintances who have died.


Trump said that after contracting the virus, he was “not in the greatest of shape.” He added that “I might not have recovered at all” without treatment with experimental drugs.

Trump’s comments on the seriousness of his case of coronavirus contrast

Read More

Donald Trump touts experimental Regeneron COVID antibody treatment

CLOSE

In a video released on Twitter, President Trump talked up the benefits of an experimental antibody drug given to treat him for COVID.

USA TODAY

In a video released Wednesday, President Donald Trump talked up the benefits of an experimental drug that he credited for “curing” him of COVID-19. He pledged to make the therapy freely available to all Americans.

Trump received REGN-COV2, made by Regeneron, a New York biotech company, after testing positive last week for the disease. The drug, a pair of monoclonal antibodies, is intended to mimic the natural process of the immune system, providing it with molecules the body normally manufactures to fight off specific diseases.

It is currently being tested in people at various stages of the disease, including patients who have been diagnosed with COVID-19 and are symptomatic but not hospitalized, as was Trump.

It also is being considered as a prophylactic treatment

Read More

Trump Hails Experimental Treatment for His Virus Recovery | Washington, D.C. News

By AAMER MADHANI, JILL COLVIN and MATTHEW PERRONE, Associated Press

WASHINGTON (AP) — President Donald Trump credited an experimental drug treatment with helping his recovery from COVID-19 and suggested his diagnosis could be a “blessing in disguise” in the nation’s battle against the pandemic. But there is no way for the president or his doctors to know whether the drug had any effect.

In a new White House video posted Wednesday evening, Trump said his illness had shed light on an experimental antibody cocktail that he tied to his improved condition. Seemingly sensitive to the fact that his treatment course has been far more comprehensive than the care received by average Americans, he promised to swiftly get the drug approved for broader use — and distribute it for free — even though he does not have the power to order that himself.

“I want everybody to be given the same

Read More

China’s experimental COVID-19 vaccine appears safe

Oct 7 (Reuters) – A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, researchers said.

In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group’s experimental shot showed no severe adverse reactions, its researchers said on Tuesday in a paper https://www.medrxiv.org/content/10.1101/2020.09.27.20189548v1 posted on medRxiv preprint server ahead of peer review.

The most common adverse reactions reported by the trial participants were mild pain, slight fatigue and redness, itching and swelling at the injection site.

The candidate also induced immune response.

“All the data obtained in this trial support the safety and immunogenicity of this inactivated vaccine and are encouraging with regard to further studies of its efficacy in the future,” the paper said.

China has inoculated hundreds of thousands

Read More

China’s Experimental COVID-19 Vaccine Appears Safe: Study | World News

(Reuters) – A Chinese experimental coronavirus vaccine being developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences was shown to be safe in an early stage clinical trial, researchers said.

In a Phase 1 trial of 191 healthy participants aged between 18 and 59, vaccination with the group’s experimental shot showed no severe adverse reactions, its researchers said on Tuesday in a paper https://www.medrxiv.org/content/10.1101/2020.09.27.20189548v1 posted on medRxiv preprint server ahead of peer review.

The most common adverse reactions reported by the trial participants were mild pain, slight fatigue and redness, itching and swelling at the injection site.

The candidate also induced immune response.

“All the data obtained in this trial support the safety and immunogenicity of this inactivated vaccine and are encouraging with regard to further studies of its efficacy in the future,” the paper said.

China has inoculated hundreds of thousands of essential workers

Read More

Trump Gets Experimental COVID Tx, Now at Walter Reed

President Trump, who announced he tested positive for COVID-19 early Friday morning, was headed to Walter Reed National Military Medical Center in the late afternoon for tests and possibly treatment.

Bloomberg reported that Trump would be staying at Walter Reed for “the next few days,” citing a statement from the White House.

An earlier statement from White House physician Sean Conley, DO, said the president had received “a single 8 gram dose of Regeneron’s polyclonal antibody cocktail,” which was completed “without incident.”

Regeneron had released topline results for its investigational REGN-COV2 antibody cocktail on Tuesday: the phase I/II/III trial showed the drug “reduced viral load and the time to alleviate symptoms in non-hospitalized patients with COVID-19,” as well as showing positive trends towards reducing medical visits.

But the product has not received FDA approval emergency use authorization yet, making it truly investigational. Some physicians on Twitter were puzzled that the

Read More

President Trump, undergoing an experimental antiviral treatment, spends a third day in the hospital.

President Trump entered his third day in the hospital on Sunday after contracting the coronavirus and falling ill last week, even as confusing and contradictory accounts about his medical condition added to the national sense of uncertainty and concern for the 74-year-old president’s well-being.

Seeking to project an optimistic image to the world, President Trump released a four-minute video on Saturday evening from Walter Reed National Military Medical Center in Bethesda, Md., to say that he is “starting to feel good” and would “be back soon.”

Wearing a blue jacket, cuff links and an American flag pin but no necktie, the president looked much paler than he did during his debate in Cleveland on Tuesday with former Vice President Joseph R. Biden Jr. Thanking the staff at Walter Reed, Mr. Trump said that he “wasn’t feeling so well” when he arrived at the hospital on Friday, but that he felt

Read More

Trump is getting medication, experimental COVID treatments: Too much?

CLOSE

President Trump’s doctor said Trump is not currently on oxygen, but would not say whether he ever received oxygen since his COVID-19 diagnosis.

USA TODAY

One potential downside to being the President of the United States — too much care. 

Presidents have always received VIP medicine, but “excessive care isn’t necessarily good quality care,” said Dr. J. Randall Curtis, a professor of pulmonary and critical care at the University of Washington School of Medicine in Seattle.

The concern is that having too much focus and too many people involved could result in over-treatment as President Donald Trump receives carefor COVID-19 at Walter Reed Military Medical Center.

At a news conference Saturday, officials said Trump’s medical team included three pulmonary critical care specialists, two infectious disease doctors, an anesthesiologist, an Army nurse, four Navy nurses, a clinical pharmacist and the director of the medical center’s executive medicine program. That’s

Read More

An army of doctors. Access to an experimental drug. A special patient gets special care.

Trump’s caregivers are sparing nothing in their attempt to treat his coronavirus infection.

From his team of providers to his helicopter flight to the hospital to the experimental drug that fewer than 10 others have received outside a clinical trial, Trump has access to care available to few of the other 7.3 million people in the United States infected so far by the coronavirus. Even with symptoms that Conley appeared to describe as moderate at worst, the 74-year-old president is the VIP of VIPs in his battle against covid-19, the disease caused by the coronavirus.

“I think about it as a realist,” said Robert Wachter, professor and chair of the department of medicine at the University of California at San Francisco. “He is the president of the United States. For him to get the most vigorous therapies . . . even if we have not yet reached the point where

Read More

Trump receiving remdesivir antiviral drug as part of experimental treatment

President Donald Trump is receiving an experimental antiviral for Covid-19 called remdesivir as he remains hospitalized at Walter Reed National Military Medical Center in Bethesda, Maryland. The drug is being given as part of a double-barreled treatment plan that includes an antibody cocktail meant to give the president’s immune system a boost to fight off the coronavirus.

The president was given the first dose of remdesivir Friday evening and will be on a five-day course of the IV drug, his physician, Dr. Sean Conley, said during a news conference Saturday.

Full coverage of the coronavirus outbreak

Remdesivir, manufactured by Gilead Sciences, works by lowering the amount of virus in the body. Clinical trial data published in May found that the drug reduced patients’ length of hospital stay by about four days, from 15 days to a median of 11 days.

In July, additional data showed remdesivir may reduce deaths.

“It’s

Read More